Author : Danylenko V.V.
Sorafenib in the treatment of iodine-negative differentiated thyroid cancerAuthors: Solodiannykova O.I. Kmetyuk Y.V. Stolyarova O.Yu. Danylenko V.V.... Т. 14, №2 (54)
Formation of radioiodine resistance in patients with differentiated thyroid cancer and possibilities of its prediction. Data from own research and literature were usedAuthors: Solodyannуkova O.I. Zelinskaya A.V. Danylenko V.V. Т. 13, № 2 (50)
Metastatic bone lesions: molecular mechanisms as new avenues of therapeutic influence. Literature reviewAuthors: Solodyannуkova O.I. Bankovska N.V. Shypko A.F. Danylenko V.V.... Т. 13, № 1 (49)
Comparative analysis of the use of radiopharmaceuticals in the treatment of bone metastasesAuthors: Solodyannуkova O.I. Danylenko V.V. Т. 12, № 3-4 (47-48)
